Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010031/S908

Amplia MRI CRT-D DTMB1D1, DTMB1D4, Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ NIK Brava CRT-D DTBC1D1 KRG, NIK Brava CRT-D D

Medtronic Cardiac Rhythm Disease Management · Decision date Dec 3, 2025

FDA DECISIONP010031/S908

What did the FDA decide?

FDA records P010031/S908 as a supplement to PMA P010031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 3, 2025.

FDA approval order statement

an update to the substrate defect mapping process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Dec 3, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P010031/S908
Regulatory pathway
PMA supplement
Product code
NIK
Decision code
OK30
Decision date
Dec 3, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D).

Product code
NIK
FDA device class
3

For the original device and its historical approval scope, see PMA P010031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010031 · Original PMA

    CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATION

  2. P010031/S899 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4); Brava Qua

  3. P010031/S898 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  4. P010031/S900 · Related supplement

    Amplia MRI CRT-D DTMB1D1, DTMB1D4; Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ; Brava CRT-D DTBC1D4; Brava CRT-D DTBC1D1;Brav

  5. P010031/S901 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4); Brava Qua

  6. P010031/S897 · Related supplement

    Cardiac Resynchronization Therapy -Defibrillator (CRT-D)

  7. P010031/S902 · Related supplement

    Cobalt MRI CRT-D; Cobalt XT MRI CRT-D; Crome MRI CRT-D

  8. P010031/S903 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4); Brava Qua

  9. P010031/S904 · Related supplement

    Cobalt MRI CRT-D DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ; Cobalt XT MRI CRTD DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ; Crome MRI CR

  10. P010031/S906 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4); Brava Qua

  11. P010031/S908 received

    Application receipt date recorded by FDA.

  12. P010031/S907 · Related supplement

    Cobalt MRI CRT-D; Cobalt XT MRI CRT-D; Crome MRI CRT-D

  13. P010031/S910 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4); Brava Qua

  14. P010031/S908 · FDA decision

    30-Day Notice

  15. P010031/S909 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  16. P010031/S905 · Related supplement

    Cobalt MRI CRT-D DTPB2D1, DTPB2D4 NIK Cobalt XT MRI CRT-D DTPA2D1, DTPA2D4 NIK Crome MRI CRT-D DTPC2D1, DTPC2D4

  17. P010031/S911 · Related supplement

    Amplia MRI CRT-D DTMB1D1, DTMB1D4 Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ Brava CRT-D DTBC1D1, DTBC1D4 Brava Quad CRT-D D

  18. P010031/S913 · Related supplement

    Cobalt MRI CRT-D; Cobalt XT MRI CRT-D; Crome MRI CRT-D

  19. P010031/S912 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  20. P010031/S915 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  21. P010031/S914 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  22. P010031/S916 · Related supplement

    Amplia MRI CRT-D DTMB1D1, DTMB1D4 Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ Brava CRT-D DTBC1D1, DTBC1D4 Brava Quad CRT-D D

  23. P010031/S919 · Related supplement

    Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

  24. P010031/S920 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  25. P010031/S921 · Related supplement

    Cobalt MRI CRT-D; Cobalt XT MRI CRT-D; Crome MRI CRT-D

  26. P010031/S923 · Related supplement

    Amplia MRI CRT-D, Amplia MRI Quad CRT-D, Brava CRT-D, Brava Quad CRT-D, Claria MRI CRT-D, Claria MRI Quad CRT-D, Cobalt

  27. P010031/S918 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome M

  28. P010031/S924 · Related supplement

    Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt

  29. P010031/S925 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRTD (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Cobalt X

  30. P010031/S922 · Related supplement

    Amplia MRI CRT-D DTMB1D4 Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ Brava CRT-D DTBC1D4 Brava Quad CRT-D DTBC1Q1, DTBC1QQ Cl

  31. P010031/S926 · Related supplement

    Amplia MRI CRT-D, Amplia MRI Quad CRT-D, Brava CRT-D, Brava Quad CRT-D, Claria MRI CRT-D, Claria MRI Quad CRT-D, Cobalt

  32. P010031/S927 · Related supplement

    Amplia MRI CRT-D DTMB1D1, DTMB1D4; Amplia MRI Quad CRTD DTMB1Q1, DTMB1QQ; Brava CRT-D DTBC1D1, DTBC1D4; Brava Quad CRT-D

  33. P010031/S928 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4);Brava Quad

  34. P010031/S929 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRTD (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome MR

  35. P010031/S930 · Related supplement

    Amplia MRI CRT-D (DTMB1D1, DTMB1D4); Amplia MRI Quad CRT-D (DTMB1Q1, DTMB1QQ); Brava CRT-D (DTBC1D1, DTBC1D4) Brava Quad

  36. P010031/S932 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  37. P010031/S933 · Related supplement

    Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

  38. P010031/S934 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  39. P010031/S931 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome M

Timeline entries are records held by MedtechLedger for P010031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010031

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Cardiac Rhythm Disease ManagementPMA approvalJun 26, 2002FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 29, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementAug 12, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementAug 12, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementSep 5, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementSep 9, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementSep 15, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 3, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 3, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 28, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementDec 3, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementDec 3, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementDec 15, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementDec 19, 2025FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJan 5, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJan 16, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJan 23, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementFeb 10, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementFeb 11, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementFeb 12, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementMar 4, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementMar 6, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementMar 27, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementApr 28, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementApr 30, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementApr 30, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementMay 15, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJun 25, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 16, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 22, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 31, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 31, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJul 31, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementSep 25, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 5, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 29, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code NIK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records